NYSE:IMUC

Immunocellular Therapeutics Stock Insider Trading

etoro logo Buy IMUC
*Your capital is at risk
$0.210
+0 (+0%)
At Close: Jun 22, 2026

ImmunoCellular Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 7.12M and sold 56.57K IMUC shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
0
Buy 7.12M shares
Sell 56.57K shares
94% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Jun 06, 2018
Buy
Common Stock
A-Award
Yu John S
Director
Director 120 000
Value: $0
Jun 06, 2018
Buy
Common Stock
A-Award
Yu John S
Director
Director 120 000
Value: $0
Dec 31, 2016
Sell
Common Stock
F-InKind
Gengos Andrew
Director
Director 3 284
Value: $7K
Dec 31, 2016
Sell
Common Stock
F-InKind
Gengos Andrew
Director
Director 3 284
Value: $7K
Jun 17, 2016
Buy
Stock Option (right to buy)
A-Award
Yu John S
Director
Director 156 750
Value: $37.6K
Jun 17, 2016
Buy
Stock Option (right to buy)
A-Award
Titus Gary
Chairman And Secretary
CEO / President 156 750
Value: $37.6K
Jun 17, 2016
Buy
Stock Option (right to buy)
A-Award
Singhvi Rahul
Director
Director 156 750
Value: $37.6K
Jun 17, 2016
Buy
Stock Option (right to buy)
A-Award
Schlossberg Mark A
Director
Director 156 750
Value: $37.6K
Jun 17, 2016
Buy
Stock Option (right to buy)
A-Award
Lapointe Anthony Gregg
Director
Director 156 750
Value: $37.6K
Jun 17, 2016
Buy
Stock Option (right to buy)
A-Award
Lapointe Anthony Gregg
Director
Director 156 750
Value: $37.6K
Jun 17, 2016
Buy
Stock Option (right to buy)
A-Award
Schlossberg Mark A
Director
Director 156 750
Value: $37.6K
Jun 17, 2016
Buy
Stock Option (right to buy)
A-Award
Singhvi Rahul
Director
Director 156 750
Value: $37.6K
Jun 17, 2016
Buy
Stock Option (right to buy)
A-Award
Titus Gary
Chairman And Secretary
CEO / President 156 750
Value: $37.6K
Jun 17, 2016
Buy
Stock Option (right to buy)
A-Award
Yu John S
Director
Director 156 750
Value: $37.6K
Mar 11, 2016
Buy
Stock Option (Right to Buy)
A-Award
Swanson Steven J
Senior Vice President, Researc
CEO / President 150 000
Value: $49.5K
Mar 11, 2016
Buy
Common Stock
A-Award
Swanson Steven J
Senior Vice President, Researc
CEO / President 25 000
Value: $0
Mar 11, 2016
Buy
Stock Option (Right to Buy)
A-Award
Fractor David
Vp Of Finance
Officer 100 000
Value: $33.0K
Mar 11, 2016
Buy
Common Stock
A-Award
Fractor David
Vp Of Finance
Officer 35 000
Value: $0
Mar 11, 2016
Buy
Stock Option (Right to Buy)
A-Award
Gringeri Anthony
Senior Vp Strategic Resources
Officer 225 000
Value: $74.3K
Mar 11, 2016
Buy
Common Stock
A-Award
Gringeri Anthony
Senior Vp Strategic Resources
Officer 75 000
Value: $0
Mar 11, 2016
Buy
Stock Option (Right to Buy)
A-Award
Gengos Andrew
President And CEO
CEO / President 350 000
Value: $115.5K
Mar 11, 2016
Buy
Common Stock
A-Award
Gengos Andrew
President And CEO
CEO / President 150 000
Value: $0
Mar 11, 2016
Buy
Common Stock
A-Award
Gengos Andrew
President And CEO
CEO / President 150 000
Value: $0
Mar 11, 2016
Buy
Stock Option (Right to Buy)
A-Award
Gengos Andrew
President And CEO
CEO / President 350 000
Value: $115.5K
Mar 11, 2016
Buy
Common Stock
A-Award
Gringeri Anthony
Senior Vp Strategic Resources
Officer 75 000
Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT IMMUNOCELLULAR THERAPEUTICS LTD
ImmunoCellular Therapeutics
Immunocellular Therapeutics, Ltd., a clinical-stage pharmaceutical company, focuses on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis. The company also dev...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.29% Jun 10
PHM
$118.49
6.02% Jun 10
EAT
$140.46
17.09% Jun 05
E
ETD
$20.67
3.19% Jun 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE